Evaluation of Etest for susceptibility testing of multidrug-resistant isolates of Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 38, Issue 12, 2000, Pages 4599-4603

  Hazbon M H ^a   Del Socorro Orozco, M ^a   Labrada, L A ^a   Tovar, R ^a   Weigle, K A ^a   Wanger, A ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG SENSITIVITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TECHNIQUE; TREATMENT PLANNING; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0034461211     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.12.4599-4603.2000     Document Type: Article

References (34)

1. Preventing multi-drug resistant tuberculosis
2. Designing a new study: Diagnostic tests
3. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis
4. Acquired multi-drug resistant TB - Buenaventura, Colombia
5. Scale of development. Theory and applications
6. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country
7. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis
8. The emergence of drug-resistant tuberculosis in New York City
9. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples
10. Etest for susceptibility of Mycobacterium tuberculosis
11. The need for global action against multidrug-resistant tuberculosis
12. Treatment and implications of multidrug-resistant tuberculosis for the 21st century
13. Encompassing treatment with prevention: The path for lasting control of tuberculosis
14. Risk factors for chronic, drug resistant tuberculosis, Buenaventura, Colombia
15. Clinical mismanagement or community outbreak? An analysis of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1999
16. Can we do better than discrepant analysis for new diagnostic test evaluation?
17. Success with the DOTS strategy
18. Global surveillance for antituberculous-drug resistance, 1994-1997
19. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: Comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group
20. Isolation of tubercle bacteria using Ogawa egg medium modified by addition of Tween 80
21. In vitro activity of antituberculous agents against Mycobacterium tuberculosis isolates from Bogota, DC (Colombia) evaluated by the Etest
22. Molecular genetic analysis of multi-drug resistance in Indian isolates of Mycobacterium tuberculosis
23. Genetics of drug resistance in tuberculosis
24. Improved outcomes for patients with multi-drug resistant tuberculosis
25. Testing Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest
26. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis